Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-27 4:30 pm Purchase |
2023-07-26 | 13G | Verastem, Inc. VSTM |
SOLEUS CAPITAL MASTER FUND, L.P. | 1,297,369 5.100% |
1,297,369 (New Position) |
Filing History |
| 2023-06-22 5:46 pm Purchase |
2023-06-21 | 13G | Verastem, Inc. VSTM |
James E. Flynn | 1,538,461 6.100% |
1,538,461 (New Position) |
Filing History |
| 2023-06-12 4:37 pm Purchase |
2023-05-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,345,192 8.000% |
1,345,192 (New Position) |
Filing History |
| 2023-06-05 5:00 pm Purchase |
2023-05-26 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% |
1,320,656 (New Position) |
Filing History |
| 2023-02-14 5:16 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 1,375,270 7.900% |
1,375,270 (New Position) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 2,249,075 13.500% |
458,106 (+25.58%) |
Filing History |
| 2023-02-13 8:16 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,674,539 9.990% |
132,359 (+8.58%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Verastem, Inc. VSTM |
BlackRock Inc. BLK |
361,445 2.300% |
-665,910 (-64.82%) |
Filing History |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,790,969 11.800% |
233,828 (+15.02%) |
Filing History |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Verastem, Inc. VSTM |
The Vanguard Group | 737,483 4.860% |
-13,565 (-1.81%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Verastem, Inc. VSTM |
BlackRock Inc. BLK |
1,027,354 6.800% |
-96,956 (-8.62%) |
Filing History |
| 2022-01-10 4:52 pm Purchase |
2022-01-06 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,542,180 10.200% |
120,333 (+8.46%) |
Filing History |
| 2022-01-10 4:49 pm Purchase |
2021-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,421,847 9.400% |
490,097 (+52.60%) |
Filing History |
| 2021-05-10 5:08 pm Purchase |
2021-04-30 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,557,141 10.900% |
711,805 (+84.20%) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
RA Capital Management, L.P. | 0 0.000% |
-760,771 (Position Closed) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Citadel Advisors LLC | 25,487 0.200% |
-512,178 (-95.26%) |
Filing History |
| 2021-02-16 4:23 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Ridgeback Capital Investments L.P. | 0 0.000% |
-839,020 (Position Closed) |
Filing History |
| 2021-02-16 4:16 pm Purchase |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 845,337 6.000% |
845,337 (New Position) |
Filing History |
| 2021-02-16 3:29 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Point72 Asset Management, L.P. | 550 0.100% |
-458,946 (-99.88%) |
Filing History |
| 2021-02-12 4:31 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Ikarian Capital LLC | 187,883 1.300% |
-233,107 (-55.37%) |
Filing History |